Explore the details of the Novartis Pharmaceuticals Corporation V. Natco Pharma Limited case under case number 1:24-cv-01367 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-01367
Filing Date
Dec 13, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Natco Pharma USA LLC -
Astex Therapeutics, Ltd. -
Novartis Pharmaceuticals Corporation -

Patents Involved in the Case

There is a single patent involved in this case.

Application NumberPatent Number
-US9868739B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Dec 13, 2024Summons Issued as to Natco Pharma Limited, Natco Pharma USA LLC, and Natco Pharma, Inc. on 12/13/2024. (Attachments: # 1 Summons Issued Natco Pharma USA LLC, # 2 Summons Issued Natco Pharma Limited)(jfm) (Entered: 12/16/2024)PACER Document
Dec 13, 2024Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka America, Inc., Other Affiliate Otsuka Pharmaceutical Co., Ltd., Other Affiliate Otsuka Holdings Co., Ltd. for Astex Therapeutics, Ltd. filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics, Ltd. (jfm) (Entered: 12/16/2024)PACER Document
Dec 13, 2024Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics, Ltd. (jfm) (Entered: 12/16/2024)PACER Document
Dec 13, 2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,868,739. (jfm) (Entered: 12/16/2024)PACER Document
Dec 13, 2024Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/30/2024. Date of Expiration of Patent: 11/9/2031.Thirty Month Stay Deadline: 4/30/2027. (jfm) (Entered: 12/16/2024)PACER Document
Dec 13, 2024Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 12/16/2024)PACER Document
Dec 13, 2024COMPLAINT for Patent Infringement against Natco Pharma Limited, Natco Pharma USA LLC, Natco Pharma, Inc. (Filing fee $ 405, receipt number ADEDC-4570150.) - filed by Astex Therapeutics, Ltd., Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jfm) (Entered: 12/16/2024)PACER Document
Dec 18, 2024Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (rjb)PACER Document
Mar 6, 2025WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation, Astex Therapeutics, Ltd.: For Natco Pharma, Inc. waiver sent on 3/5/2025, answer due 5/5/2025. (Joyce, Alexandra) (Entered: 03/06/2025)PACER Document
Mar 6, 2025WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation, Astex Therapeutics, Ltd.: For Natco Pharma USA LLC waiver sent on 3/5/2025, answer due 5/5/2025. (Joyce, Alexandra) (Entered: 03/06/2025)PACER Document
Mar 6, 2025WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation, Astex Therapeutics, Ltd.: For Natco Pharma Limited waiver sent on 3/5/2025, answer due 5/5/2025. (Joyce, Alexandra) (Entered: 03/06/2025)PACER Document
Apr 29, 2025STIPULATION of Dismissal with Prejudice by Astex Therapeutics, Ltd., Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 04/29/2025)PACER Document
May 1, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,868,739. (Attachments: # 1 Stipulation of Dismissal)(ceg) (Entered: 05/01/2025)PACER Document
May 1, 2025SO ORDERED, re 11 Stipulation of Dismissal with prejudice. (***Civil Case Terminated). Signed by Judge Jennifer L. Hall on 5/1/2025. (ceg) (Entered: 05/01/2025)PACER Document
Feb 20, 2025CORRECTING ENTRY: The Oral Order at D.I. 8 has been removed from the docket as it was filed in error. (ceg)PACER Document